摘要
目的探讨区域药学协作的糖尿病药物治疗管理服务模式对糖尿病患者自护能力及血糖控制的影响。方法联合区域内社区药师,选取2020年4月至7月门诊就诊的128例糖尿病患者为研究对象,采用随机数字表法分为对照组和观察组各64例,对照组给予常规糖尿病管理模式,观察组给予区域药学协作的糖尿病药物治疗管理模式,即与医联体区域内社区医院药师联合为患者提供药物治疗管理,均干预6个月,对比2组干预前后糖尿病管理知识(SDSCA)评分、用药依从性Morisky评分及血糖控制情况。结果观察组干预后SDSCA总分及Morisky评分均显著高于干预前[(69.60±8.10)分vs(52.17±13.30)分,(7.51±0.67)分vs(6.67±1.22)分],且均显著高于对照组[(61.62±12.96)分,(6.67±1.22)分],差异均有统计学意义(P<0.05)。观察组和对照组干预后的空腹血糖(FBG)和糖化血红蛋白(HbAlc)均低于干预前[对照组:(7.74±1.63)mmol/L vs(7.82±1.49)mmol/L;(7.66±1.54)%vs(7.96±1.91)%;观察组:(6.91±1.19)mmol/L vs(7.83±2.81)mmol/L;(7.14±0.99)%vs(8.00±1.73)%],且干预后的水平观察组低于对照组(P<0.05)。观察组患者FBG控制率为85.94%,高于对照组的57.81%(P<0.01);HbAlc的控制率为76.56%,高于对照组的50.00%(P<0.01)。结论区域药学协作的糖尿病药物治疗管理服务可有效提高糖尿病患者自我健康管理能力及血糖控制水平。
Objective To explore the effect of regional pharmaceutical cooperationmodel on self-care ability and blood glucose management in diabetic patients.Methods A total of 128 outpatients with diabetes were selected as the study objects from April 1st to July 31th 2020,and randomly divided into the control group and the observation group,with 64 cases in each group.The patients in the control group was given a routine diabetes management model for 6 months.The patients in the observation group was given a regional pharmaceutical collaboration model of the diabetic medication therapy management for same time.The scores of SDSCA,Morisky and blood glucose control were compared before and after the intervention between the two groups.Results The SDSCA total score and Morisky score after the intervention were(69.60±8.10)and(7.51±0.67),respectively.Those scores were significantly higher than the scores before intervention(52.17±13.30)and(6.67±1.22),respectively(P<0.05).And those were also significantly higher than the scores after intervention of the control group,(61.62±12.96)and(6.67±1.22),respectively(P<0.05).The FBG and HbAlc level of the two groups after the intervention were significantly lower than those before the intervention[control group:FBG(7.74±1.63)mmol/L afetr vs(7.82±1.49)mmol/L before,HbAlc(7.66±1.54)%after vs(7.96±1.91)%before.Observation group:FBG(6.91±1.19 mmol/L after vs(7.83±2.81 mmol/L before,HbAlc(7.14±0.99)%after vs(8.00±1.73)%before](P<0.05).And the FBG and HbAlc level after intervention in the collaboration group were significantly lower than the control group(P<0.05).The control rate of FBG and HbAlc in the observation group were 85.94%and 76.56%,which were all significantly higher than those in the control group 57.81%and 50.00%,respectively(P<0.01).Conclusion Regional pharmaceutical collaboration model in diabetes drug management services can improve self-management ability and blood sugar control level of diabetic patients.
作者
刘彦儒
刘小林
龚婧如
陆惠平
朱琦敏
赵辉
周卫英
汪勇东
LIU Yan-ru;LIU Xiao-lin;GONG Jing-ru;LU Hui-ping;ZHU Qi-min;ZHAO Hui;ZHOU Wei-ying;WANG Yong-dong(Department of Pharmacy,Shanghai Pudong Hospital,Shanghai 201399,China;Department of Pharmacy,Shanghai Pudong New Area Geriatric Hospital,Shanghai 201314,China;Pudong New Area Wanxiang Community Health Service Center,Shanghai 201313,China;Pudong New Area Datuan Community Health Service Center,Shanghai 201311,China;Pudong New Area Xuanqiao Community Health Service Center,Shanghai 201314,China)
出处
《东南国防医药》
2021年第5期475-478,共4页
Military Medical Journal of Southeast China
基金
上海市浦东新区卫生系统重要薄弱学科资助(PWZbr2017-15)
复旦大学附属浦东医院重点专科专病诊治中心项目(Tszk2020-05)。
